Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 04-2001 | 12-2000 | 04-2000 | 12-1999 | 04-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,251 | N/A | 5,466 | 5,466 | 0 |
| Receivables | N/A | 0 | 400 | 400 | 0 |
| Other current assets | 30 | 110 | 0 | 71 | 0 |
| TOTAL | $4,364 | $110 | $5,938 | $5,938 | $0 |
| Non-Current Assets | |||||
| PPE Net | 244 | N/A | 32 | 32 | 0 |
| Intangibles | 234 | 0 | 231 | 0 | 0 |
| Other Non-Current Assets | 0 | 230 | 0 | 230 | 0 |
| TOTAL | $478 | $230 | $262 | $262 | $0 |
| Total Assets | $4,842 | $340 | $6,200 | $6,200 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 87 | 0 | 212 | 210 | 0 |
| Accrued Expenses | 80 | N/A | 89 | 80 | 0 |
| TOTAL | $344 | $N/A | $345 | $345 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $0 |
| Total Liabilities | $344 | $N/A | $345 | $345 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14 | N/A | N/A | N/A | N/A |
| Common Shares | 845 | N/A | 809 | 800 | 0 |
| Retained earnings | -12,986 | N/A | -11,313 | -11,313 | 0 |
| Other shareholders' equity | 94 | 0 | 1,935 | 1,948 | 0 |
| TOTAL | $4,498 | $N/A | $5,854 | $5,854 | $0 |
| Total Liabilities And Equity | $4,842 | $0 | $6,200 | $6,200 | $0 |